Drug & Supplement Interactions

K2/Spice + Opicapone

Brand name of Opicapone

  • Ongentys

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Best Avoided

We found no known interaction between K2/Spice and Opicapone in our sources, but our pharmacy team rates K2/Spice itself best avoided. These products are illegal, unregulated, and have caused serious harm and death.

This also applies to Ongentys, a brand name of opicapone.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking K2/Spice with Opicapone. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

K2/Spice and Opicapone Interaction Check

No Known Interaction, but K2/Spice Is Best Avoided

We did not find a documented interaction between Opicapone and K2/Spice in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Our pharmacy team rates K2/Spice best avoided, whatever else you take. These products are illegal, unregulated, and have caused serious harm and death. See K2/Spice’s safety ratings →

How We Checked

Why No Interaction Is Listed for Opicapone

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category Opicapone is in against every category K2/Spice has a known interaction with.

3Categories Opicapone Is In
  • Dopamine Agonists No K2/Spice Record
  • P-Glycoprotein Substrates Drugs that a pump called P-glycoprotein moves out of cells in the gut, liver and kidneys; when the pump slows or speeds up, their levels can rise or fall. No K2/Spice Record
  • Oral Drugs Any drug taken by mouth. No K2/Spice Record
2Drug Categories K2/Spice Interacts With

No overlap. Opicapone is in none of the 2 categories K2/Spice interacts with, so no record links the two.

Still wondering about combining K2/Spice and Opicapone? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

Side Effects K2/Spice and Opicapone Have in Common

8 side effects show up for both K2/Spice and Opicapone.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • 3 of them are worth acting on rather than waiting out, marked below.
  • Hallucinations Worth Acting On reported in 13.9% of FDA reports for Opicapone Additional detail

    K2/Spice

    When inhaled, K2/spice can cause agitation, psychosis, delirium, hallucinations, paranoia, anxiety, confusion, altered mental status, panic attacks, aggressive behaviors, and suicidality. Agitation, which escalates to delirium and psychosis, appears to be the most common acute psychiatric adverse effect reported after K2/spice use, occurring in up to 41% of toxicity cases.

    Source: , the clinical database we license.

    6 references cited
    1. 98847. Davidson C, Opacka-Juffry J, Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E, Molina-Holgado F. Spicing up pharmacology: a review of synthetic cannabinoids from structure to adverse events. Adv Pharmacol 2017;80:135-68. PubMed
    2. 98848. Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: a case report. Clin Schizophr Relat Psychoses 2015;8(4):205-8. DOI
    3. 99616. Lamy FR, Daniulaityte R, Nahhas RW, et al. Increases in synthetic cannabinoids-related harms: results from a longitudinal web-based content analysis. Int J Drug Policy. 2017;44:121-9. PubMed
    4. 99617. Law R, Schier J, Martin C, Chang A, Wolkin A; Centers for Disease Control (CDC). Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015. MMWR Morb Mortal Wkly Rep 2015;64(22
    5. 99618. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014;144:12-41. PubMed
    6. 99619. Monte AA, Calello DP, Gerona RR, et al. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. J Med Toxicol 2017;13(2):146-52. PubMed

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Opicapone’s label on DailyMed ›
  • Confusion Worth Acting On Additional detail

    K2/Spice

    When inhaled, K2/spice can cause drowsiness, lethargy, vertigo, ataxia, hyperreflexia, nystagmus, confusion, anxiety, cognitive impairment, emotional dysregulation, seizures, and coma. Numerous cases of seizures secondary to K2/spice use have been reported.

    Source: , the clinical database we license.

    6 references cited
    1. 99616. Lamy FR, Daniulaityte R, Nahhas RW, et al. Increases in synthetic cannabinoids-related harms: results from a longitudinal web-based content analysis. Int J Drug Policy. 2017;44:121-9. PubMed
    2. 99617. Law R, Schier J, Martin C, Chang A, Wolkin A; Centers for Disease Control (CDC). Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015. MMWR Morb Mortal Wkly Rep 2015;64(22
    3. 99619. Monte AA, Calello DP, Gerona RR, et al. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. J Med Toxicol 2017;13(2):146-52. PubMed
    4. 99621. Schwartz MD, Trecki J, Edison LA, Steck AR, Arnold JK, Gerona RR. A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA. J Emerg Med 2015;48(5):573-80. PubMed
    5. 99624. Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila) 2016;54(1):1-13. PubMed
    6. 103080. Kourouni I, Mourad B, Khouli H, Shapiro JM, Mathew JP. Critical Illness Secondary to Synthetic Cannabinoid Ingestion. JAMA Netw Open. 2020;3(7):e208516. PubMed

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Raised blood pressure Worth Acting On Additional detail

    K2/Spice

    When inhaled, K2/spice can cause serious adverse cardiovascular effects, including tachycardia or bradycardia, hypertension or hypotension, coronary vasospasm, acute coronary syndrome, congestive heart failure, ventricular fibrillation, QT prolongation, myocardial ischemia/infarction, stroke, cardiac arrest, cardiomyopathy, and sudden cardiac death.

    Source: , the clinical database we license.

    6 references cited
    1. 98843. Andonian DO, Seaman SR, Josephson EB. Profound hypotension and bradycardia in the setting of synthetic cannabinoid intoxication - a case series. Am J Emerg Med 2017;35(6):940.e5-940.e6. PubMed
    2. 98844. McIlroy G, Ford L, Khan JM. Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report. BMC Pharmacol Toxicol 2016;17:2. PubMed
    3. 98846. Clark BC, Georgekutty J, Berul CI. Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients. J Pediatr 2015;167(3):757-61.e1. PubMed
    4. 98849. Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS. Ischemic stroke after use of the synthetic marijuana "spice". Neurology 2013;81(24):2090-3. PubMed
    5. 99617. Law R, Schier J, Martin C, Chang A, Wolkin A; Centers for Disease Control (CDC). Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015. MMWR Morb Mortal Wkly Rep 2015;64(22
    6. 99619. Monte AA, Calello DP, Gerona RR, et al. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. J Med Toxicol 2017;13(2):146-52. PubMed

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Dry mouth Additional detail

    K2/Spice

    Recorded for K2/Spice in the same Natural Medicines adverse-effect record shown under Hallucinations above.

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Drowsiness Additional detail

    K2/Spice

    When inhaled, K2/spice has been associated with hepatitis. In one case, a 45-year-old male presenting with somnolence, lethargy, and fatigue after smoking 2 grams of K2/spice daily for one week was found to have evidence of hepatocellular necrosis and worsening liver failure. The patient was treated with N-acetylcysteine and made a full recovery.

    Source: , the clinical database we license.

    2 references cited
    1. 99622. Sheikh IA, Luksic M, Ferstenberg R, Culpepper-Morgan JA. Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine. Am J Case Rep 2014;15:584-8. PubMed
    2. 104896. Ahmed ST, Alam A, Hassan A, Kamal S, Mahmood M. Acute Liver Failure Caused by Synthetic Marijuana Use. Am J Ther. 2020. doi: 10.1097/MJT.0000000000001181. PubMed

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Low blood pressure Additional detail

    K2/Spice

    Recorded for K2/Spice in the same Natural Medicines adverse-effect record shown under Hallucinations above.

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Trouble sleeping Additional detail

    K2/Spice

    Recorded for K2/Spice in the same Natural Medicines adverse-effect record shown under Hallucinations above.

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Dizziness Additional detail

    K2/Spice

    Recorded for K2/Spice in the same Natural Medicines adverse-effect record shown under Confusion above.

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›

Reported for K2/Spice but not commonly for Opicapone: heart failure, a heart attack, memory problems and shortness of breath.

Note: Effects for Opicapone come from the Adverse Reactions section of its FDA label; effects for K2/Spice come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 2,261 voluntary FDA FAERS reports for Opicapone that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. The two sources word some effects differently, so we match them by meaning.

If You Already Take Both
  • Tell your pharmacist or doctor that you take K2/Spice, so they can check it against everything else you take.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

K2/Spice Does Interact With Other Medications

K2/Spice has 208 moderate known drug interactions in our database — Opicapone isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against K2/Spice

Covers the 2,830 medications we’ve checked against K2/Spice. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Opicapone

Take other supplements too? 59 supplements have a documented interaction with Opicapone, each explained on its page.

By severity: 2 major, 40 moderate and 17 minor.

The Most Serious There Right Now:

Open the Opicapone interaction pageEvery supplement checked against Opicapone, ranked by severity

Get to Know Each One

About K2/Spice and Opicapone

Supplement

About K2/Spice

K2/Spice is NOT a herbal supplement — it is plant material sprayed with man-made synthetic cannabinoid chemicals. It is dangerous, unpredictable, and has caused seizures, heart problems, psychosis, and deaths, so it should not be used.

Full K2/Spice guide: uses, dosage, safety and every interaction
Safety at a Glance

How K2/Spice Is Rated

  • K2/Spice Overall

    Avoid

    These products are illegal, unregulated, and have caused serious harm and death.

  • Pregnancy

    Avoid

    Never use during pregnancy; it can seriously harm both mother and baby.

  • Breastfeeding

    Avoid

    Avoid while breastfeeding; chemicals can pass to the infant and cause harm.

Medication

About Opicapone

Brand name: Ongentys

Opicapone (sold as Ongentys capsules) is used along with levodopa/carbidopa in people with Parkinson’s disease who have “off” episodes. These are times when Parkinson’s symptoms return between doses of levodopa.

Opicapone: uses, dosage and side effects Opicapone: interactions with other drugs Taking more than these two? Check K2/Spice and Opicapone with everything else you take Opicapone NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & K2/Spice

Browse every other medication we’ve checked against K2/Spice — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
208Moderate
0Minor
2,621No known interaction
Moderate

Moderate: 208 interactions

Showing 60 of 208 moderate interactions — see all 208 on the K2/Spice page.

No Interaction 2,621 drugs checked — show the list
How Much People Look This Up

Where K2/Spice and Opicapone Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement K2/Spice
Top half

#542 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Opicapone
Top half

#1,353 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking K2/Spice and Opicapone Together: Common Questions

Can you take K2/Spice with Opicapone?
We do not list a known interaction between K2/Spice and Opicapone, but that is not a reason to take K2/Spice: our pharmacy team rates it best avoided, whatever else you take. These products are illegal, unregulated, and have caused serious harm and death. Talk with your pharmacist or doctor before taking it, and do not stop or change Opicapone on your own.
Can you take K2/Spice with Ongentys?
Ongentys is a brand name of opicapone, so the answer is the same as for opicapone. We do not list a known interaction between K2/Spice and Opicapone, but that is not a reason to take K2/Spice: our pharmacy team rates it best avoided, whatever else you take. Everything on this page applies to Ongentys too.
Do K2/Spice and Opicapone have any of the same side effects?
Yes — our sources link each of them separately to 8 of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the K2/Spice and Opicapone combination checked?
Interactions in our licensed database are recorded against drug classes. Opicapone is filed under 3 classifications, and K2/Spice has documented interactions with 2 drug classes — none of Opicapone's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does K2/Spice interact with any other medications?
Yes. K2/Spice has 208 documented drug interactions in our database — Opicapone is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Opicapone interact with any supplements?
Yes. Opicapone has documented interactions with 59 supplements in our database — K2/Spice is not one of them. The Opicapone interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 15 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 15 references
  1. 98843. Andonian DO, Seaman SR, Josephson EB. Profound hypotension and bradycardia in the setting of synthetic cannabinoid intoxication - a case series. Am J Emerg Med 2017;35(6):940.e5-940.e6. PubMed
  2. 98844. McIlroy G, Ford L, Khan JM. Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report. BMC Pharmacol Toxicol 2016;17:2. PubMed
  3. 98846. Clark BC, Georgekutty J, Berul CI. Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients. J Pediatr 2015;167(3):757-61.e1. PubMed
  4. 98847. Davidson C, Opacka-Juffry J, Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E, Molina-Holgado F. Spicing up pharmacology: a review of synthetic cannabinoids from structure to adverse events. Adv Pharmacol 2017;80:135-68. PubMed
  5. 98848. Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: a case report. Clin Schizophr Relat Psychoses 2015;8(4):205-8. DOI
  6. 98849. Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS. Ischemic stroke after use of the synthetic marijuana "spice". Neurology 2013;81(24):2090-3. PubMed
  7. 99616. Lamy FR, Daniulaityte R, Nahhas RW, et al. Increases in synthetic cannabinoids-related harms: results from a longitudinal web-based content analysis. Int J Drug Policy. 2017;44:121-9. PubMed
  8. 99617. Law R, Schier J, Martin C, Chang A, Wolkin A; Centers for Disease Control (CDC). Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015. MMWR Morb Mortal Wkly Rep 2015;64(22
  9. 99618. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014;144:12-41. PubMed
  10. 99619. Monte AA, Calello DP, Gerona RR, et al. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. J Med Toxicol 2017;13(2):146-52. PubMed
  11. 99621. Schwartz MD, Trecki J, Edison LA, Steck AR, Arnold JK, Gerona RR. A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA. J Emerg Med 2015;48(5):573-80. PubMed
  12. 99622. Sheikh IA, Luksic M, Ferstenberg R, Culpepper-Morgan JA. Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine. Am J Case Rep 2014;15:584-8. PubMed
  13. 99624. Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila) 2016;54(1):1-13. PubMed
  14. 103080. Kourouni I, Mourad B, Khouli H, Shapiro JM, Mathew JP. Critical Illness Secondary to Synthetic Cannabinoid Ingestion. JAMA Netw Open. 2020;3(7):e208516. PubMed
  15. 104896. Ahmed ST, Alam A, Hassan A, Kamal S, Mahmood M. Acute Liver Failure Caused by Synthetic Marijuana Use. Am J Ther. 2020. doi: 10.1097/MJT.0000000000001181. PubMed

All 40 references behind our K2/Spice records are listed in the K2/Spice guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The K2/Spice and Opicapone records this page draws on were last updated October 20, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About K2/Spice and Opicapone?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.